Providence Business News

Embrace Home Loans Sponsoring Stars and Stripes Veteran Golf Tournament on September 9, 2022

Retrieved on: 
Tuesday, August 16, 2022 - 2:00pm

MIDDLETOWN, R.I., Aug. 16, 2022 /PRNewswire/ -- Embrace Home Loans, a top-ranked lender in the mortgage industry, announced that their Fairfax, Virginia office will sponsor the Stars and Stripes Golf Tournament, which will be hosted by the Veterans Association of Real Estate Professionals (VAREP) of Northern Virginia. The tournament will be held on Friday, September 9, 2022, in Quantico, VA.

Key Points: 
  • Embrace Senior Loan Officer David Aikman, Fairfax, Virginia, is the vice president of the Northern Virginia chapter of VAREP and is coordinating the golf tournament.
  • He will also be sponsoring some of his veteran clients who are interested in playing in the tournament to show his gratitude for their service.
  • "The Stars and Stripes Veteran Charity Golf tournament provides a fun day of golf while raising money to aid many local veterans in need.
  • As with previous Stars and Stripes Golf Tournaments, there will be prizes for hole-in-one, closest to the pin, and longest drive.

Bragar Eagel & Squire, P.C. Is Investigating NIO, Discover, MINISO, and Phathom and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, August 16, 2022 - 2:00am

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, NIO's American depositary receipt ("ADR") price fell $2.75 per ADR, or 15.17%, to close at $15.38 per ADR on May 5, 2022.
  • For more information on the Phathom investigation go to: https://bespc.com/cases/PHAT
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Bragar Eagel & Squire, P.C. Is Investigating Phathom, TuSimple, Mercury Systems, and Cassava and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, August 11, 2022 - 2:00am

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Finally, the Company announced that [t]hese additional activities will result in a delay of the planned VOQUEZNA DUAL PAK and VOQUEZNA TRIPLE PAK product launches.
  • For more information on the Cassava investigation go to: https://bespc.com/cases/SAVA
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

ROSEN, A LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors with Losses Exceeding $100K to Inquire About Securities Class Action Investigation – PHAT

Retrieved on: 
Thursday, August 11, 2022 - 12:15am

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=7943 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, A LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT

Retrieved on: 
Saturday, August 6, 2022 - 6:16pm

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=7943 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=7943 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Bragar Eagel & Squire, P.C. Is Investigating MINISO, Digital World, Verano, and Phathom and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, August 6, 2022 - 2:00am

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On July 26, 2022, Blue Orca Capital (Blue Orca) published a short report concerning MINISO.
  • For more information on the Phathom investigation go to: https://www.bespc.com/cases/PHAT
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

PHATHOM ALERT: Bragar Eagel & Squire, P.C. is Investigating Phathom Pharmaceuticals, Inc. on Behalf of Phathom Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, August 5, 2022 - 2:00am

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Phathom Pharmaceuticals, Inc. (Phathom or the Company) (NASDAQ: PHAT) on behalf of Phathom stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Phathom Pharmaceuticals, Inc. (Phathom or the Company) (NASDAQ: PHAT) on behalf of Phathom stockholders.
  • Our investigation concerns whether Phathom has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Phathoms stock price fell $2.61 per share, or 28%, to close at $6.46 per share on August 2, 2022.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

PHATHOM ALERT: Bragar Eagel & Squire, P.C. is Investigating Phathom Pharmaceuticals, Inc. on Behalf of Phathom Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, August 4, 2022 - 2:00am

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Phathom Pharmaceuticals, Inc. (Phathom or the Company) (NASDAQ: PHAT) on behalf of Phathom stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Phathom Pharmaceuticals, Inc. (Phathom or the Company) (NASDAQ: PHAT) on behalf of Phathom stockholders.
  • Our investigation concerns whether Phathom has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Phathoms stock price fell $2.61 per share, or 28%, to close at $6.46 per share on August 2, 2022.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Phathom Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Wednesday, August 3, 2022 - 4:40pm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Phathom Pharmaceuticals, Inc. (Phathom or the Company) (NASDAQ: PHAT ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Phathom Pharmaceuticals, Inc. (Phathom or the Company) (NASDAQ: PHAT ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • Phathom issued a press release on August 2, 2022, titled: Phathom Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Updates.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Phathom Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Tuesday, August 2, 2022 - 10:59pm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Phathom Pharmaceuticals, Inc. (Phathom or the Company) (NASDAQ: PHAT ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Phathom Pharmaceuticals, Inc. (Phathom or the Company) (NASDAQ: PHAT ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • Phathom issued a press release on August 2, 2022, titled: Phathom Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Updates.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.